Bridging knowledge and practice gaps in pharmacovigilance: a study among medical interns in Uttar Pradesh
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20254148Keywords:
Adverse drug reactions, Pharmacovigilance, Medical interns, Knowledge-attitude-practice, ADR reporting, IndiaAbstract
Background: Adverse drug reactions (ADRs) are a major public health concern globally, contributing to significant morbidity and mortality. Despite the presence of pharmacovigilance systems, underreporting is common within medical colleges and antimicrobial stewardship programs, particularly in India. Medical interns are pivotal in ADR reporting, but gaps persist between their knowledge and practical application. By integrating pharmacovigilance into medical curricula, healthcare professionals can be better equipped to identify and report ADRs, ultimately enhancing patient outcomes. This study aims to evaluate the knowledge, attitudes, and practices (KAP) of ADR reporting among medical interns at Sarojini Naidu Medical College, Agra, and identify barriers to reporting.
Methods: A cross-sectional study was conducted among 125 medical interns using a pre-tested, structured questionnaire to assess their KAP regarding ADR reporting. Data were analyzed using descriptive statistics in Microsoft Excel.
Results: While 95% of interns were aware of ADRs and 70% understood the need to report them, only 25% had reported an ADR. Barriers included time constraints, lack of training, and legal concerns.
Conclusion: The study highlights high awareness but low reporting rates among medical interns, emphasizing the need for targeted educational interventions and streamlined reporting systems to improve pharmacovigilance practices.
Metrics
References
World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions. WHO Press. 2020. Available at: https://www.who.int/publications/i/item/WHO-EDM-QSM-2002-2. Accessed on 15 October 2025.
Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability, and costs of Adverse Drug Reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016;81:323-34. DOI: https://doi.org/10.1016/j.vascn.2016.04.011
Pharmacovigilance Programme of India (PvPI). Guidelines for Adverse Drug Reaction Reporting. Indian Pharmacopoeia Commission. 2019.
Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Begaud B. Incidence of serious adverse drug reactions in general practice: A prospective study. Clin Pharmacol Ther. 2001;69:458-62. DOI: https://doi.org/10.1067/mcp.2001.116145
Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc. Patient Saf. 2012;4:75-80. DOI: https://doi.org/10.2147/DHPS.S29287
Posthumus AA, Alingh CC, Zwaan CC, van Grootheest KK, Hanff LL, Witjes BB, et al. Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open. 2012;2(4):e000934. DOI: https://doi.org/10.1136/bmjopen-2012-000934
World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions. Geneva: WHO/EDM/QSM/2002.2. 2002.
Protocol of National Pharmacovigilance Programme, November 2004. CDSCO, Ministry of Health and Family Welfare, Government of India. November. 2004. Available at: http://www.cdsco.nic.in/html/ Pharmacovigilance%20protocol% 20.pdf. Accessed on 15 October 20252.
Tandon VR, Mahajan V, Khajuria V, Gullani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65-71. DOI: https://doi.org/10.4103/0253-7613.150344
Datta D, Giri VP. A Questionnaire Study on the Knowledge, Attitude, and Practice of Pharmacovigilance among the Medical Post Graduates in a Teaching Hospital in West Uttar Pradesh. Int Arch BioMed Clin Res. 2017;3(2):25-31. DOI: https://doi.org/10.21276/iabcr.2017.3.2.6
Mittal N, Gupta M, Singla M. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India. Cutan Ocul Toxicol. 2014;33(4):289-93. DOI: https://doi.org/10.3109/15569527.2013.857678
Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta Analysis. PLoS One. 2016;11(3):e0152221. DOI: https://doi.org/10.1371/journal.pone.0152221
Datta S, Sengupta S. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. Perspect Clin Res. 2015;6:200-6. DOI: https://doi.org/10.4103/2229-3485.167096
Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci. 2012;66:55-61. DOI: https://doi.org/10.4103/0019-5359.110902
Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions – A way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62:381-5. DOI: https://doi.org/10.1007/s00228-005-0072-0
Downloads
Published
How to Cite
Issue
Section
